Welcome to DFA2023, we have a superstar line-up of international and national experts presenting at future focused DFD plenary sessions and practical workshops across the two days. Once again, we're elevating the experience with a pre-conference mini symposium, our always entertaining social events and a special Charcot Masterclass. Our aim for you to leave rejuvenated and inspired. Most importantly though, we're focusing on the content that matters. DFA 2023 is all about relaxed learning and networking with old friends and new. We can't wait to welcome you as we head back to nature at the Novotel Sunshine Coast. DFA 2023 is an in-person conference.
DFA MINI SYMPOSIUM
Sunday 3:00pm - 5:00pm - Novotel
DFA is hosting a special pre-conference mini symposium where we’re inviting multi-disciplinary health professionals, researchers and organisations to discuss:
- Where national DFD research is at currently
- Lessons and learnings from our international experts on collaborative research programs
- What’s needed next and how to get involved
In this interactive session, we want to hear from you. As we work towards bringing the DFD community together to conduct research that makes a real difference and supports new innovations in clinical care delivery.
Sunday 6:00pm - 8:00pm - Novotel Convention Centre Arrivals Lounge
FULL CONFERENCE DELEGATE PASS
Join us on Sunday night as we kick off the DFA2023 Conference in relaxed style. This is a wonderful opportunity to catch with up old friends, meet new friends and enjoy the DFA Poster Showcase. With drinks, a selection of substantial canapes all included, join us as we kick off the conversation and catch up.
This event also includes the DFA Poster Session from 6:15pm - 6:50pm where we will be showcasing the newest and brightest research works from around Australia and internationally. To view all presentations and timings - please download the official conference program.
Re-set that work/life balance and enjoy the resort location. Novotel Sunshine Coast Resort is an absolute haven, offering a pristine beachfront location framed by natural bushland. The resort wraps itself around the private beach-lined lagoon and a short stroll down the private path will have you dipping your feet in the ocean in no time. With a restaurant, bar and café on-site and Maroochydore a short 10min Uber drive away - it's the perfect time to learn the latest about DFD and enjoy some well deserved R&R.
From bench to bedside – translating research into clinical practice
Today’s cutting-edge research is tomorrow’s best practice clinical care | Professor David Armstrong (USA)
Using data to inform and reform | A/Professor Pete Lazzarini
How do we go from knowing research to implementing into clinical practice? | Dr Emma Hamilton
Key research considerations in First Nations Peoples health | Professor James Charles
Live panel discussion + Q&A with all speakers
WORKSHOP 1
Personalised medicine - isn’t this what we’ve been doing all our lives, or is implementation challenging?
Featuring A/Professor Jaap van Netten with A/Professor Byron Perrin
WORKSHOP 2
Charcot Masterclass
Featuring A/Professor Katherine Raspovic and Professor Dane Wukich (USA)
WORKSHOP 3
Wound bed preparation, dressings and current technologies
Featuring Dr Pam Chen with Ms Hayley Ryan
| Collecting your own data - how do you run a study in a clinical practice?
Featuring Professor David Armstrong with Dr Emma Hamilton |
| Integrating best practice offloading into your clinical practice
Featuring A/Professor Pete Lazzarini with Professor Stephen Twigg |
| The inclusion of culture in DFD management for Aboriginal and Torres Strait Islander Peoples + VR technology
Featuring Professor James Charles with Professor Viv Chuter |
| SESSION 1: DIABETES-RELATED FOOT DISEASE AND CLINICAL CARE
Prospective randomised placebo-controlled trial assessing the efficacy of silver dressings to enhance healing of acute diabetes-related foot ulcers VITAFOOT- a double-blind, randomised controlled trial of micronutrient supplementation in people with non-healing diabetes-related foot ulcers Optimal temperature stabilisation period after Total Contact Cast (TCC) removal for assessing dermal temperatures in active Charcot neuro-osteoarthropathy Evaluation of behavioural therapy for adults with diabetes-related foot disease on measures of self-care behaviour, coping, psychological distress and glycaemic control Most individuals with diabetes-related foot ulceration do not meet dietary consensus guidelines for wound healing Diabetic foot wound swabs useful or useless? A mixed methods study |
| SESSION 2: OUTCOMES FROM THE ABORIGINAL AND TORRES STRAIT ISLANDER DIABETES-RELATED FOOT COMPLICATIONS PROGRAM
An overview of the Aboriginal and Torres Strait Islander Diabetes-related Foot Complications Program The strengths of embedding co-designed diabetes-related foot complications programs in Aboriginal community controlled health services “If you can’t feel Country beneath your feet, something’s wrong”: Foot Stomp in Southern Adelaide “Look at Me!” Foot Health Education for Aboriginal Health Workforce Enhancing Amputation Care for Aboriginal People in South Australia Evaluating the national Aboriginal and Torres Strait Islander diabetes-related Foot Complications program |
| SESSION 3: PRACTICAL PARTNER WORKSHOPS
WORKSHOP 1: PRESENTED BY URGO MEDICAL Take Control of Infection Infection cannot wait. Join Dr Pavan Belehalli along with clinical specialists for a session of discovery as we present the NEW UrgoClean Ag and UrgoTul Ag, the complete range you need to fight against VITAFOOT- a double-blind, local infection. WORKSHOP 2: PRESENTED BY MEDIRENT Using compression pumps in the management of complicated lower leg and foot disorders |
Practices in Prevention
What role does personalised medicine play in preventing DFD? | A/Professor Jaap van Netten (NLD)
Burden & prevention of diabetes-related foot disease in North Queensland | Professor Jon Golledge
Working with the patient for best wellbeing outcomes | A/Professor Anita Raspovic
Live panel discussion + Q&A with all speakers
Presentation of Outstanding Achievement Award
From bench to bedside – translating research into clinical practice
Today’s cutting-edge research is tomorrow’s best practice clinical care | Professor David Armstrong (USA)
Using data to inform and reform | A/Professor Pete Lazzarini
How do we go from knowing research to implementing into clinical practice? | Dr Emma Hamilton
Key research considerations in First Nations Peoples health | Professor James Charles
Live panel discussion + Q&A with all speakers
WORKSHOP 1
Personalised medicine - isn’t this what we’ve been doing all our lives, or is implementation challenging?
Featuring A/Professor Jaap van Netten with A/Professor Byron Perrin
WORKSHOP 2
Charcot Masterclass
Featuring A/Professor Katherine Raspovic and Professor Dane Wukich (USA)
WORKSHOP 3
Wound bed preparation, dressings and current technologies
Featuring Dr Pam Chen with Ms Hayley Ryan
| Collecting your own data - how do you run a study in a clinical practice?
Featuring Professor David Armstrong with Dr Emma Hamilton |
| Integrating best practice offloading into your clinical practice
Featuring A/Professor Pete Lazzarini with Professor Stephen Twigg |
| The inclusion of culture in DFD management for Aboriginal and Torres Strait Islander Peoples + VR technology
Featuring Professor James Charles with Professor Viv Chuter |
Prospective randomised placebo-controlled trial assessing the efficacy of silver dressings to enhance healing of acute diabetes-related foot ulcers
Eva Staunton - Royal Melbourne Hospital
VITAFOOT- a double-blind, randomised controlled trial of micronutrient supplementation in people with non-healing diabetes-related foot ulcers
Dr Emma Hamilton - Fiona Stanley Hospital
Optimal temperature stabilisation period after Total Contact Cast (TCC) removal for assessing dermal temperatures in active Charcot neuro-osteoarthropathy
Justin Bradley - Monash Health
Evaluation of behavioural therapy for adults with diabetes-related foot disease on measures of self-care behaviour, coping, psychological distress and glycaemic control
Dr Melanie Burkhardt - Fiona Stanley Hospital
Most individuals with diabetes-related foot ulceration do not meet dietary consensus guidelines for wound healing
Hailey Donnelly - University of Newcastle
Diabetic foot wound swabs useful or useless? A mixed methods study
Dr Denise Kee - Sunshine Coast University Hospital
An overview of the Aboriginal and Torres Strait Islander Diabetes-related Foot Complications Program
Kim Morey and Astrid Melcher - SAHMRI
The strengths of embedding co-designed diabetes-related foot complications programs in Aboriginal community controlled health services
Laura Stuart & Courtney Fairfull - Congress & Kimberley Aboriginal Medical Services
“If you can’t feel Country beneath your feet, something’s wrong”: Foot Stomp in Southern Adelaide
Duncan Langford Glass & Saraid Martin - Flinders University, SALHN
“Look at Me!” Foot Health Education for Aboriginal Health Workforce
Beth Tiernan - University of South Australia
Enhancing Amputation Care for Aboriginal People in South Australia
Joseph Agius & Saraid Martin - SAHMRI/CALHN/AHCSA/Uni Adelaide
Evaluating the national Aboriginal and Torres Strait Islander diabetes-related Foot Complications program
Tina Brodie - SAHMRI
SESSION 3: PRACTICAL PARTNER WORKSHOPS
WORKSHOP 1: PRESENTED BY URGO MEDICAL
Take Control of Infection
Infection cannot wait. Join Dr Pavan Belehalli along with clinical specialists for a session of discovery as we present the NEW UrgoClean Ag and UrgoTul Ag, the complete range you need to fight against VITAFOOT- a double-blind, local infection.
WORKSHOP 2: PRESENTED BY MEDIRENT
Using compression pumps in the management of complicated lower leg and foot disorders
Learn from podiatrist Dr. Sylvia McAra, about considerations for implementing a comprehensive treatment plan in complex cases and how SIPC can be utilised safely in the management of oedema, pain and wounds of the feet and legs.
Practices in Prevention
What role does personalised medicine play in preventing DFD? | A/Professor Jaap van Netten (NLD)
Burden & prevention of diabetes-related foot disease in North Queensland | Professor Jon Golledge
Working with the patient for best wellbeing outcomes | A/Professor Anita Raspovic
Live panel discussion + Q&A with all speakers
Presentation of Outstanding Achievement Award
The URGO Medical Local Treatment: From Wound Infection to Complete Healing
Join Dr Pavan Belehalli and discover our simple, effective and reliable solution which allows you to take
control of healing, improve clinical outcomes and quality of life for your patients. (LIMITED SPACES)
All about the wound - latest strategies to heal wounds
Classifying the wound to determine the best management plan | Professor Matilde Monterio Soares (PRT) VIRTUAL
Choosing the right duration of antibiotics | A/Professor Laurens Manning
Treating peripheral artery disease to heal ischemic wounds | Professor Rob Fitridge
Wound healing interventions – hype or hope? | Dr Pam Chen
Applying offloading to achieve wound healing | A/Professor Pete Lazzarini
Live panel discussion + Q&A with all speakers
SESSION 1: OUTCOMES FROM DIVERSE DFD HEALTH SERVICES
Racial Disparities in Major and Minor Lower Extremity Amputations and Timing to Amputation Following Diabetes Related Complications | Professor Dane Wukich - University of Texas Southwestern
Trends in Inpatient Diabetes-related Foot Disease (DFD) in an Australian hospital setting: a ten-year longitudinal analysis | Huy Do - Western Health
The use of non-removable knee-high offloading devices to treat plantar diabetes-related foot ulcers within a regional Australian health context | Ifeoluwapo Tokun - Townsville Hospital & Services
Podiatry and Hospital in the Home; A pilot study in a regional setting | Adam McLean - Bendigo Health
Eastern Health High Risk Foot Service Database and HARP ED Diversion Pathway | Michaela Watts - Eastern Health
SESSION 2: FIRST NATION PEOPLES AND REGIONAL AUSTRALIANS DFD HEALTH
Retrospective review of amputation rates in Aotearoa New Zealand | Sean Gray - Peke Waihanga NZ
Collaborative Inpatient and Community Care: A Novel Approach to Diabetes-Related Foot Disease for Regional and Rural Victoria | John Chen LCHS/LRH - Gippsland HRFC
Improving access to High Risk Foot Services for First Nations people through community outreach clinics - Approaching First Nations Foot Disease within Aboriginal Community Health Organisations in Regional and Rural Victoria | Dr Scott McNeil - Alfred Health/Gippsland High Risk Foot
Looking After Feet (Ingke Arntarnte-areme) program Co-designing foot health resources led by Communities in central Australia | James Gerrard - Central Australian Aboriginal Congress
PRESENTED BY EBOS HEALTHCARE: PARTNER WORKSHOP 1
Outsmarting PAD the easy way
Join Kerrie Coleman NP, for this interactive workshop to assist health professionals understand the rationale for assessing patients regularly for PAD.
PRESENTED BY PROFESSOR JAMES CHARLES: PARTNER WORKSHOP 2
VR Dreaming experience with Professor James Charles
VR Dreaming is an immersive interactive experience that transports participants back 20,000 years to my Kaurna community. I share some Dreaming stories, knowledge of astronomy, traditional medicines, therapies, and treatments. (LIMITED SPACES)
| Collecting your own data - how do you run a study in a clinical practice?
Featuring Professor David Armstrong (USA) with Dr Emma Hamilton |
| PAD from a podiatry perspective
Featuring Professor Viv Chuter with Professor Rob Fitridge |
| Charcot Masterclass
Featuring A/Professor Katherine Raspovic (USA) and Professor Dane Wukich (USA) |
| DFD from a psychological perspective
Featuring A/Professor Anita Raspovic with Dr Emma Hamilton |
| Personalised medicine - isn’t this what we’ve been doing all our lives, or is implementation challenging?
Featuring A/Professor Jaap van Netten (NLD) with A/Professor Byron Perrin |
| Wound bed preparation, dressings and current technologies
Featuring Dr Pam Chen with Ms Hayley Ryan |
What's new and predictors for the future
IWGDF Charcot guideline and new thinking around surgical management | A/Professor Katherine Raspovic (USA)
Postcodes matter - geographical indicators of disease | Dr Susanna Cramb
AI is here - what role can it play in treating DFD? | Professor David Armstrong (USA)
Live panel discussion + Q&A with all speakers
Thank you and conference close
Stay tuned as we announce details in August (limited seats available)
All about the wound - latest strategies to heal wounds
Classifying the wound to determine the best management plan | Professor Matilde Monterio Soares (PRT) VIRTUAL
Choosing the right duration of antibiotics | A/Professor Laurens Manning
Treating peripheral artery disease to heal ischemic wounds | Professor Rob Fitridge
Wound healing interventions – hype or hope? | Dr Pam Chen
Applying offloading to achieve wound healing | A/Professor Pete Lazzarini
Live panel discussion + Q&A with all speakers
Racial Disparities in Major and Minor Lower Extremity Amputations and Timing to Amputation Following Diabetes Related Complications | Professor Dane Wukich - University of Texas Southwestern
Trends in Inpatient Diabetes-related Foot Disease (DFD) in an Australian hospital setting: a ten-year longitudinal analysis | Huy Do - Western Health
The use of non-removable knee-high offloading devices to treat plantar diabetes-related foot ulcers within a regional Australian health context | Ifeoluwapo Tokun - Townsville Hospital & Services
Podiatry and Hospital in the Home; A pilot study in a regional setting | Adam McLean - Bendigo Health
Eastern Health High Risk Foot Service Database and HARP ED Diversion Pathway | Michaela Watts - Eastern Health
Retrospective review of amputation rates in Aotearoa New Zealand | Sean Gray - Peke Waihanga NZ
Collaborative Inpatient and Community Care: A Novel Approach to Diabetes-Related Foot Disease for Regional and Rural Victoria | John Chen LCHS/LRH - Gippsland HRFC
Improving access to High Risk Foot Services for First Nations people through community outreach clinics - Approaching First Nations Foot Disease within Aboriginal Community Health Organisations in Regional and Rural Victoria | Dr Scott McNeil - Alfred Health/Gippsland High Risk Foot
Looking After Feet (Ingke Arntarnte-areme) program Co-designing foot health resources led by Communities in central Australia | James Gerrard - Central Australian Aboriginal Congress
PRESENTED BY EBOS HEALTHCARE: PARTNER WORKSHOP 1
Outsmarting PAD the easy way
Join Kerrie Coleman NP, for this interactive workshop to assist health professionals understand the rationale for assessing patients regularly for PAD.
PRESENTED BY PROFESSOR JAMES CHARLES: PARTNER WORKSHOP 2
VR Dreaming experience with Professor James Charles
VR Dreaming is an immersive interactive experience that transports participants back 20,000 years to my Kaurna community. I share some Dreaming stories, knowledge of astronomy, traditional medicines, therapies, and treatments. (LIMITED SPACES)
| Collecting your own data - how do you run a study in a clinical practice?
Featuring Professor David Armstrong (USA) with Dr Emma Hamilton |
| PAD from a podiatry perspective
Featuring Professor Viv Chuter with Professor Rob Fitridge |
| Charcot Masterclass
Featuring A/Professor Katherine Raspovic (USA) |
| DFD from a psychological perspective
Featuring A/Professor Anita Raspovic with Dr Emma Hamilton |
| Personalised medicine - isn’t this what we’ve been doing all our lives, or is implementation challenging?
Featuring A/Professor Jaap van Netten (NLD) with A/Professor Byron Perrin |
| Wound bed preparation, dressings and current technologies
Featuring Dr Pam Chen with Ms Hayley Ryan |
What's new and predictors for the future
IWGDF Charcot guideline and new thinking around surgical management | A/Professor Katherine Raspovic (USA)
Postcodes matter - geographical indicators of disease | Dr Susanna Cramb
AI is here - what role can it play in treating DFD? | Professor David Armstrong (USA)
Live panel discussion + Q&A with all speakers
Thank you and conference close
From bench to bedside – translating research into clinical practice
Today’s cutting-edge research is tomorrow’s best practice clinical care | Professor David Armstrong (USA)
Using data to inform and reform | A/Professor Pete Lazzarini
How do we go from knowing research to implementing into clinical practice? | Dr Emma Hamilton
Key research considerations in First Nations Peoples health | Professor James Charles
Live panel discussion + Q&A with all speakers
Monday 7:00pm - 10:00pm - Novotel FULL CONFERENCE DELEGATES
Join us on Monday night for our always entertaining, interactive dinner. This year, we're under the stars and taking full advantage of our resort location. With a mix of interactive food stations, an array of drinks, get ready for good conversation, great company and good vibes!
Practices in Prevention
What role does personalised medicine play in preventing DFD? | A/Professor Jaap van Netten (NLD)
Burden & prevention of diabetes-related foot disease in North Queensland | Professor Jon Golledge
Working with the patient for best wellbeing outcomes | A/Professor Anita Raspovic
Live panel discussion + Q&A with all speakers
Presentation of Outstanding Achievement Award
Personalised medicine - isn’t this what we’ve been doing all our lives, or is implementation challenging?
Featuring A/Professor Jaap van Netten with A/Professor Byron Perrin
Collecting your own data - how do you run a study in a clinical practice?
Featuring Professor David Armstrong with Dr Emma Hamilton
Charcot Masterclass
Featuring A/Professor Katherine Raspovic and Professor Dane Wukich
Wound bed preparation, dressings and current technologies
Featuring Dr Pam Chen with Ms Hayley Ryan
Download the full program to see when the workshops are happening!
The International Working Group on the Diabetic Foot (IWGDF) has published evidence-based guidelines on the prevention and management of diabetic foot disease since 1999. And the just released 2023 IWGDF Guidelines, includes the first guideline on the diagnosis and treatment of active Charcot Neuro-osteoarthropathy in persons with diabetes published by the IWGDF. We are so very lucky to have both the chair and the secretary from the 2023 IWGDF Charcot Guideline joining us at DFA2023 where you can learn the latest in person at our special Charcot Masterclass offered on both Monday 09 Oct and Tues 10 Oct.
| SESSION 1
Prospective randomised placebo-controlled trial assessing the efficacy of silver dressings to enhance healing of acute diabetes-related foot ulcers VITAFOOT- a double-blind, randomised controlled trial of micronutrient supplementation in people with non-healing diabetes-related foot ulcers Optimal temperature stabilisation period after Total Contact Cast (TCC) removal for assessing dermal temperatures in active Charcot neuro-osteoarthropathy Evaluation of behavioural therapy for adults with diabetes-related foot disease on measures of self-care behaviour, coping, psychological distress and glycaemic control Most individuals with diabetes-related foot ulceration do not meet dietary consensus guidelines for wound healing Diabetic foot wound swabs useful or useless? A mixed methods study |
| SESSION 2:
An overview of the Aboriginal and Torres Strait Islander Diabetes-related Foot Complications Program The strengths of embedding co-designed diabetes-related foot complications programs in Aboriginal community controlled health services “If you can’t feel Country beneath your feet, something’s wrong”: Foot Stomp in Southern Adelaide “Look at Me!” Foot Health Education for Aboriginal Health Workforce Enhancing Amputation Care for Aboriginal People in South Australia Evaluating the national Aboriginal and Torres Strait Islander diabetes-related Foot Complications program |
All about the wound - latest strategies to heal wounds
Classifying the wound to determine the best management plan | Professor Matilde Monterio Soares (PRT) VIRTUAL
Choosing the right duration of antibiotics | A/Professor Laurens Manning
Treating peripheral artery disease to heal ischemic wounds | Professor Rob Fitridge
Wound healing interventions – hype or hope? | Dr Pam Chen
Applying offloading to achieve wound healing | A/Professor Pete Lazzarini
Live panel discussion + Q&A with all speakers
SESSION 1: OUTCOMES FROM DIVERSE DFD HEALTH SERVICES
Racial Disparities in Major and Minor Lower Extremity Amputations and Timing to Amputation Following Diabetes Related Complications | Professor Dane Wukich - University of Texas Southwestern
Trends in Inpatient Diabetes-related Foot Disease (DFD) in an Australian hospital setting: a ten-year longitudinal analysis | Huy Do - Western Health
The use of non-removable knee-high offloading devices to treat plantar diabetes-related foot ulcers within a regional Australian health context | Ifeoluwapo Tokun - Townsville Hospital & Services
Podiatry and Hospital in the Home; A pilot study in a regional setting | Adam McLean - Bendigo Health
Eastern Health High Risk Foot Service Database and HARP ED Diversion Pathway | Michaela Watts - Eastern Health
SESSION 2: FIRST NATION PEOPLES AND REGIONAL AUSTRALIANS DFD HEALTH
Retrospective review of amputation rates in Aotearoa New Zealand | Sean Gray - Peke Waihanga NZ
Collaborative Inpatient and Community Care: A Novel Approach to Diabetes-Related Foot Disease for Regional and Rural Victoria | John Chen LCHS/LRH - Gippsland HRFC
Improving access to High Risk Foot Services for First Nations people through community outreach clinics - Approaching First Nations Foot Disease within Aboriginal Community Health Organisations in Regional and Rural Victoria | Dr Scott McNeil - Alfred Health/Gippsland High Risk Foot
Deadly Feet: a codesign process for the implementation of an early foot screening program for Aboriginal and Torres Strait Islander Peoples | Samantha Cullen - Queensland Health MNHHS
Looking After Feet (Ingke Arntarnte-areme) program Co-designing foot health resources led by Communities in central Australia | James Gerrard - Central Australian Aboriginal Congress
7:50am - 8:30am OFFICIAL PARTNER BREAKFAST SESSION
The URGO Medical Local Treatment: From Wound Infection to Complete Healing
Join Dr Pavan Belehalli and discover our simple, effective and reliable solution which allows you to take control of healing, improve clinical outcomes and quality of life for your patients. (LIMITED SPACES)
We're taking over the Sunshine Coast Convention Centre. And with all session rooms within a short stroll, there's plenty of time and opportunity to network, relax and...couch. The convention centre is located on-site at the Novotel Sunshine Coast and is a short stroll from the resort to the conference.
Download the full program to see when the workshops are happening!
PAD from a podiatry perspective
Featuring Professor Viv Chuter with Professor Rob Fitridge
DFD from a psychological perspective
Featuring A/Professor Anita Raspovic with Dr Emma Hamilton
Integrating best practice offloading into your clinical practice
Featuring A/Professor Pete Lazzarini with
Professor Stephen Twigg
The inclusion of culture in DFD management for Aboriginal and Torres
Strait Islander Peoples + intro to VR technology experience
Featuring Professor James Charles with Professor Viv Chuter
What's new and predictors for the future
IWGDF Charcot guideline and new thinking around surgical management | A/Professor Katherine Raspovic (USA)
Postcodes matter - geographical indicators of disease | Dr Susanna Cramb
AI is here - what role can it play in treating DFD? | Professor David Armstrong (USA)
Live panel discussion + Q&A with all speakers
Thank you and conference close
Infection cannot wait.
Join Dr Pavan Belehalli along with clinical specialists for a session of discovery as we present the NEW UrgoClean Ag and UrgoTul Ag, the complete range you need to fight against VITAFOOT- a double-blind, local infection.
Learn from podiatrist Dr. Sylvia McAra, about considerations for implementing a comprehensive treatment plan in complex cases and how SIPC can be utilised safely in the management of oedema, pain and wounds of the feet and legs.
The goals of wound healing, reducing pain, maintaining independence, and preventing infection/ cellulitis are routine work for podiatrists. However, each of these management goals are negatively impacted by chronic oedema, which regularly exists in limbs, feet and toes that may superficially "appear normal" in shape and size. Specific assessment techniques including palpation, can reveal the presence and type of oedematous tissue that may be non-pitting and may not look grossly swollen. This elucidation can provide clarity of assessment that then informs clinical decision-making with increased acumen and effectiveness to add to multidisciplinary team management.
Topic:
Sequential Intermittent Pneumatic Compression (SIPC) is gaining momentum as an effective treatment modality. Learn from podiatrist Dr. Sylvia McAra, about considerations for implementing a comprehensive treatment plan in complex cases and how SIPC can be utilised safely in the management of oedema, pain and wounds of the feet and legs.
The seminar presents a number of case studies, demonstrating assessment and treatment principles, in addition to the use of compression pumps in the management of complex presentations. The cases include mixed aetiology wounds (venous/arterial/ lymphatic pathology), with symptoms of pain, lymphorrhea, wounds, dermatological conditions.
Speaker: Dr. Sylvia McAra, Podiatrist
Sylvia McAra PhD, has spent 13 years as a university educator and has worked in public and private clinical practice for 38 years. Her ground-breaking work from her PhD project involved using vascular toe pressure to measure outcomes using transdermal glyceryl trinitrate in peripheral arterial disease. Sylvia has multiple peer-reviewed publications and regularly presents a range of education to health practitioners from GP and hospital clinics to Allied Health services.
Outsmarting PAD the easy way
This interactive workshop will assist health professionals to understand the rationale for assessing patients regularly for PAD.
The workshop will outline the following information:
- To discuss and examine if there is a gap in PAD screening routinely and if so, what are the barriers to implementing this
- What are the current methods and equipment used to screen for PAD, this will be aligned with the newly released guidelines, and the use of the Wi-Fi assessment tool
- How to read and understand reports – Pulse wave velocity versus doppler velocity waveform (ABPI)
- Using the MESI TBI equipment, gain problem-solving skills required to this system.
- The use of a Doppler as a tool to assist with diagnosing peripheral vascular disease for those patients at risk of PAD
With a range of direct flights and easy connections from capital cities and New Zealand, it takes longer to walk through the Sunshine Coast (MCY) airport than to transfer to the resort! New airline BONZA have also released a range of new regional routes flying direct to the Sunshine Coast. Flights and transfers from Brisbane Airport are also available.
When it comes to enjoying the comforts of home along with the in-room amenities of Australia’s best 4-star resorts, Novotel Sunshine Coast Resort blends contemporary style and design. 373 rooms are available including Resort Rooms, Executive Rooms, One and Two Bedroom Suites and beautifully appointed Overwater Bungalows. The Sebel is also located within walking distance of the Novotel Sunshine Coast with a range of accommodation also available at Maroochydore which is a short ten minute drive away. Free parking is also available at the convention centre for those driving. On the Novotel Sunshine Coast website enter the PROMO CODE: DIABF23 to see the 'special rate' when you are viewing the rooms available. There's also additional accommodation available to book at Maroochydore itself. These are mostly located is a short 8 minute cab/taxi ride away from the Sunshine Coast Convention Centre if looking for more accommodation options to book.
Meet our
Speakers!
Dr. Armstrong is Professor of Surgery at the University of Southern California. Dr. Armstrong holds a Master of Science in Tissue Repair and Wound Healing from the University of Wales College of Medicine and a PhD from the University of Manchester College of Medicine, where he was appointed Visiting Professor of Medicine. He is founder and co-Director of the Southwestern Academic Limb Salvage Alliance (SALSA).
Dr. Armstrong has produced more than 620 peer-reviewed research papers in dozens of scholarly medical journals as well as over 100 books or book chapters. He is co-Editor of the American Diabetes Association’s (ADA) Clinical Care of the Diabetic Foot, now in its third edition.
Armstrong was appointed Deputy Director of Arizona’s Center for Accelerated Biomedical Innovation (ACABI) and co-founder of its “augmented human” initiative, which places him at the nexus of the merger of consumer electronics, wearables and medical devices.
Dr. Armstrong was selected as one of the first six International Wound Care Ambassadors and is the recipient of numerous awards and degrees by universities and international medical organizations including the inaugural Georgetown Distinguished Award for Diabetic Limb Salvage. In 2008, he was the 25th and youngest-ever member elected into the Podiatric Medicine Hall of Fame. He was the first surgeon to be appointed University Distinguished Outreach Professor at the University of Arizona. He was the first podiatric surgeon to become a member of the Society of Vascular Surgery and the first US podiatric surgeon named fellow of the Royal College of Surgeons, Glasgow. He is the 2010 and youngest ever recipient of the ADA’s Roger Pecoraro Award, the highest award given in the field.
Dr. Armstrong is past Chair of Scientific Sessions for the ADA’s Foot Care Council, and a past member of the National Board of Directors of the American Diabetes Association. He sits on the Infectious Disease Society of America’s (IDSA) Diabetic Foot Infection Advisory Committee and is the US appointed delegate to the International Working Group on the Diabetic Foot (IWGDF). Dr. Armstrong is the founder and co-chair of the International Diabetic Foot Conference (DF-Con), the largest annual international symposium on the diabetic foot in the world. He is also the Founding President of the American Limb Preservation Society (ALPS), an interdisciplinary medical and surgical society dedicated to eliminating preventable amputation in the USA and worldwide.
Katherine M. Raspovic, D.P.M., is an Associate Professor in the Department of Orthopaedic Surgery and the Department of Plastic Surgery at UT Southwestern Medical Center and is a Doctor of Podiatric Medicine. Her clinical specialties include medical and surgical treatment of the foot and ankle and treatment of diabetes-related lower extremity complications.
Dr. Raspovic earned her undergraduate degree at Miami University (Oxford, Ohio) and her doctoral degree in podiatric medicine at Des Moines University College of Podiatric Medicine and Surgery. She completed her residency in podiatric surgery and fellowship in orthopaedic foot and ankle surgery at the University of Pittsburgh Medical Center.
Her clinical interests include all aspects of foot and ankle reconstructive surgery, especially complex Charcot surgical reconstruction. Much of Dr. Raspovic’s research focuses on assessing and managing diabetic foot disease. She serves as Co-Director of the Diabetic Limb Salvage Service at UTSW, has published a number of scholarly articles, delivered numerous invited and research-related presentations, and co-authored a chapter in The Diabetic Foot.
Dr. Raspovic is a Fellow of the American College of Foot and Ankle Surgeons (ACFAS) and also serves on the ACFAS Fellowship Committee. She is a past Chair of the American Diabetes Association Interest Group on Foot Care and a member of the Association of Diabetic Foot Surgeons, the American Podiatric Medical Association, and the American Diabetes Association. She is the also the secretary of the IWGDF 2023 Charcot Guideline Working Group.
Dr Jaap van Netten, PhD, is a human movement scientist from the Netherlands, specialized in clinical research on foot disease. His research focus is on the interplay between biomechanics and behaviour in the prevention of foot ulcers and amputation. This includes real-life and laboratory gait and activity analyses, communication strategies, footwear optimization and e-health solutions for disease detection and behaviour changes.
Van Netten has research and clinical experience from academic and non-academic research settings in the Netherlands and Australia. He works as senior researcher and academic clinician at Amsterdam UMC, the Netherlands, and has a position as adjunct associate professor at QUT, Brisbane, Australia. As senior researcher at Amsterdam UMC, he coordinates, supervises and performs numerous research projects on diabetic foot disease. Clinically, he works as a human movement scientist in the gait lab, measuring and analysing plantar pressure, physical activity and adherence in patients who visit the multidisciplinary diabetic foot clinic at the centre.
He also serves as scientific secretary of the International Working Group on the Diabetic Foot (IWGDF) editorial board and prevention working group, responsible for the international guidelines on diabetic foot disease. He is also involved with (DIALECT) who aim to provide unique world-class interdisciplinary and intersectoral research and training to a new generation of high-achieving doctoral candidates in the areas of biomechanics, activity behaviour, sensor development, and footwear related to diabetes-related foot disease.
Matilde Monteiro-Soares is a podiatrist from the North of Portugal. She has dedicated her professional and academic experience mainly to diabetic foot prevention, diagnostic and treatment. She has gathered clinical experience in a high risk setting Diabetic Foot Clinic with a multidisciplinary team and started to investigate, develop and improve the classification of subjects with diabetes by their risk of foot complications.
Her MSc and PhD degrees focused on Clinical and Health Services Research and diabetic foot complications’ prediction and prevention. Since 2011, she collaborates with the MEDCIDS department, in Oporto University, lecturing in pre- and post-graduate courses mainly about evidence-based healthcare, diagnostic and prognostic studies, evidence synthesis and health technology assessment. Since 2019, she is an Invited Assistant teacher there.
She is a Research integrated member at Center for Health Technology and Services Research (CINTESIS), Oporto Faculty of Medicine. She belongs to the EvidenS&HTA Research Group, Thematic Line 3 – Health Data and Decision Sciences & Information Technologies.
Since 2019, she started to teach as external collaborator in the Podiatry licentiate degree at Portuguese Red Cross Health School in Lisbon and since 2021 she is the coordinator of that course.
She is also a Member of the Portuguese Diabetic Foot Study Group (GEPED), Portuguese Research and Development of Podiatry Society (SPIDP), Portuguese Wound Treatment Association (APTF) – Diabetic Foot Group, and ‘Prevention of the First Ulcer’ Group from the Diabetic Foot Study Group (DFSG).
Dane K. Wukich, M.D., is Professor and Chair of the Department of Orthopaedic Surgery at UT Southwestern, where he holds the Dr. Charles F. Gregory Chair in Orthopaedic Surgery. He is also the Medical Director of Orthopaedic Surgery at UT Southwestern University Hospitals.
Dr. Wukich received his undergraduate education from Carnegie-Mellon University and earned his medical degree at Georgetown University School of Medicine. He completed his general surgery residency and orthopaedic surgery residency at Walter Reed Army Medical Center, followed by a fellowship in foot and ankle surgery at the Cleveland Clinic Foundation.
As an Army Medical Corps officer, Dr. Wukich served as a chief of orthopaedic surgery in Operations Desert Storm and Desert Shield. He achieved the rank of Major with the U.S. Army, receiving several Army Commendation Medals and an Army Achievement Medal. Dr. Wukich also received the Southwest Asia Services Medal and the National Defense Service Ribbon.
Dr. Wukich is a nationally renowned foot and ankle specialist, educator, lecturer, and researcher. He has written more than 100 papers and given invited lectures around the globe. He serves as peer reviewer for 11 journals, and is the author or co-author of several book chapters dealing with foot and ankle problems in athletes and patients with diabetes. His research interest includes the complications of circular external fixation in patients with diabetes, foot and ankle problems in post-transplant patients, and treatment of spastic deformities of the foot and ankle in patients with traumatic brain injury and/or stroke.
He remains actively involved in the education of orthopaedic surgery not only around the world but also here at UT Southwestern with orthopaedic residents.
Dr. Wukich is board certified by the American Board of Orthopaedic Surgery, and is a member of numerous professional organizations, including the American Academy of Orthopaedic Surgeons, the American Orthopaedic Foot and Ankle Society, the American Orthopaedic Association, and the American Diabetes Association.
A/Prof Anita Raspovic is a registered podiatrist and registered psychologist (with AHPRA). She graduated with podiatry honours from La Trobe University (1992), and went on to complete a Doctor of Philosophy by research (2006), a Graduate Certificate in Higher Education Curriculum, Teaching and Learning (2011), a Graduate Diploma in Psychology (2015), Honours in Psychology (2018) and a Master of Clinical Psychology at La Trobe University (2021). Across her career, Anita has worked in a diverse range of roles in academia, research, allied health, higher education and in clinical practice, including public sector podiatry practice and more recently private psychology practice. She is currently Associate Professor and the Course Co-ordinator for the Discipline of Podiatry at La Trobe University, and she is a Senior Research Fellow in Eating Disorders in the School of Psychology & Public Health, also at La Trobe University.
Dr Raspovic was a member of the 2019 and 2023 International Working Group on the Diabetic Foot (IWGDF) Prevention Guideline reviews and she acted as Chair for the Prevention Chapter of the 2021 Diabetic Foot Australia, evidence-based guidelines. Anita has published widely, including plantar pressure trials, offloading, mechanical alterations in diabetes gait and prevention of diabetes-related foot ulceration. More recently she has undertaken research on the relationship between body image and health behaviours, peer mentoring in eating disorders and research workforce capacity building.
Professor James Charles is a Kaurna man from Adelaide, South Australia, an Aboriginal scholar, podiatrist, and Director of Griffith University’s First Peoples Health Unit. Throughout his career, Professor Charles has worked in and with Aboriginal communities, and with leading Universities, educating on providing culturally appropriate health care. Professor Charles was Chairperson of Indigenous Allied Health Australia 2009 – 2010, and Chairperson of the Indigenous Allied Health Australia Network 2008. Prof Charles was very proud to be a representative on the national “Close the Gap” committee in 2008-2009, and was very honoured to receive the national NAIDOC “Scholar of the Year” award in 2017 for his teaching, research and work in the Aboriginal community. He has also received the prestigious Alumni Accolade Award from the University of South Australia in 2018, and the outstanding Alumni Achiever Award from the University of Newcastle 2019. Prof Charles has received a UNESCO achievement award for scientific education in 2019. Prof Charles has conducted many research projects and published many research papers on Aboriginal health in peer-reviewed journals and several book chapters.
James was also an integral member in developing the 2021 Australian guidelines for diabetes-related disease, in particular the guideline considerations for Aboriginal and Torres Strait Islanders Peoples health.
Dr Chen is a podiatrist and early career researcher specialising in diabetes-related foot disease. Having completed her PhD at UTAS, which focused on health literacy and improving diabetes-related foot ulcer prevention, she returned to WA for new challenges.
Pam is currently developing a new multi-disciplinary foot ulcer service at Joondalup Health Campus and also works as a senior podiatrist at SCGH. Pam is the national President of the Advanced Practicing Podiatrists – High Risk Foot Group in Australia and sits on a number of committees and networks relating to diabetic foot disease nationally. She is passionate about translational research and evidence-based practice, and has more recently been involved with the 2021 Australian evidence-based guidelines for diabetes-related foot disease as Secretary of the Wound Healing chapter. Pam is also part of the International Working Group of the Diabetic Foot – 2023 update on Guidelines on the use of interventions to enhance healing of foot ulcers in persons with diabetes as scientific Secretary.
Associate Professor Pete Lazzarini is a podiatrist by background and is now a Principal Research Fellow with Queensland University of Technology and Queensland Health in Brisbane, Australia.
Pete has an emerging international track record in diabetes-related foot disease research, and he holds an Early Career Fellowship with the Australian National Health and Medical Research Council. His research interests are in the epidemiology and treatment of foot disease and he is especially interested in research that prevents foot disease hospitalisation and amputation.
He has published >125 papers, delivered >110 (inter)national conference presentations and attracted >$3.6 million in grant funding in the field. And he serves on multiple (inter)national diabetic foot committees, including immediate past Chair of Diabetes Feet Australia and Secretary of the International Working Group on the Diabetic Foot Offloading Guideline
Pete is particularly motivated by nurturing the next generation of researchers to develop policy and practice strategies that help end avoidable amputations within a generation.
Dr Emma Hamilton is an Endocrinologist at Fiona Stanley and Fremantle Hospitals, Clinical Senior Lecturer at UWA and Clinical Lead of the Multidisciplinary Diabetes Foot Unit at Fiona Stanley Hospital, an NADC accredited Centre of Excellence High Risk Foot Service. Emma completed her Endocrinology training in Western Australia before moving to Melbourne to complete a PhD “Control of Musculoskeletal Function and Body Composition by Androgens in Males” under the supervision of Professor Jeffrey Zajac and Dr Mathis Grossmann at the University of Melbourne, Austin Health. Since returning to WA, Emma continues to pursue her clinical and research interests in androgens, diabetes, osteoporosis and diabetes-related foot complications as well as a long term research collaboration with Professor Tim Davis and the Fremantle Diabetes Study team. Aligning her research priorities with her clinical work, Emma was awarded a Raine Clinician Research Fellowship to further her research in diabetes-related foot disease, with the aim of improving outcomes for people living with diabetes and foot complications. Emma serves on a number of national diabetes-related foot disease projects and committees including the NADC Diabetic Foot Network working party, NADC interdisciplinary High Risk Foot Service accreditation committee, the Foot Forward Executive Advisory team, the DFA Australian Research Priorities project, DFA Australian guidelines Wound Classification group and is also a member of the IWGDF Wound Classification guideline group.
Prof Rob Fitridge (MBBS, MS, FRACS) is Professor of Vascular Surgery at University of Adelaide, and Consultant Vascular Surgeon with the Central Adelaide Local Health Network (Royal Adelaide Hospital and The Queen Elizabeth Hospital). He is also head of the Multi-Disciplinary Foot (MDF) Service at The Queen Elizabeth Hospital and Lyell McEwin Health Service, which he co-founded in the mid-1990s, and is co-head of the MDF service at the Royal Adelaide Hospital. His contributions to surgical science have been recognised with an ad hominem membership with the Fellows of the Royal College of Surgeons in Edinburgh.
He is most recognised for his work on predictive modelling of outcomes after endovascular aneurysm surgery (NHMRC-funded with 15 related publications). He was a member of the steering committee for the Global Guidelines for Chronic Limb-threatening Ischaemia (CLTI), and also contributed to the GLASS anatomical staging system and to the ESVS Acute Limb Ischaemia guideline. He is managing editor for Mechanisms of Vascular Disease: A Textbook for Vascular Specialists, widely used for training in Australia and now in its third edition. He is actively involved in undergraduate and postgraduate student teaching, as well as curriculum development for vascular surgical training.
Prof Fitridge has extensive clinical and research experience in management of chronic complex wounds, with 20 publications in the last five years in the field of limb salvage with a combined citation index over seven times the field average. He was a member of the Baker IDI/NHMRC and Diabetes Feet Australia working groups, which developed national guidelines for the management of the diabetic foot; he is also a member of the International Working Group for the Diabetic Foot (and co-chair of its Peripheral Arterial Disease committee), which develops and updates internationally-recognised guidelines for the assessment and management of diabetes-related foot disease. Prof Fitridge is a core partner with the Australian Centre for Accelerating Diabetes Innovations (ACADI), where he is a lead in the diabetic foot syndrome priority area.
Dr Susanna Cramb, PhD, is an epidemiologist, biostatistician and NHMRC Emerging Leader in the Australian Centre for Health Services Innovation, Queensland University of Technology. Her research focus is to identify and understand health inequities, particularly for chronic disease and injuries. Closely collaborating with multiple industry partners including Jamieson Trauma Institute and Cancer Council Queensland, her work has directly informed government policy aimed at reducing cancer inequities based on residential location.
Susanna is ranked second nationally for her research in disease mapping, was appointed a Superstar of STEM by Science and Technology Australia (2019/2020 cohort), a Queensland Young Tall Poppy by the Australian Institute of Policy and Science in 2020, and received the Ian Griffiths Best Abstract Award at DFA 2021.
Jonathan is Professor of Vascular Surgery at The Townsville University Hospital and James Cook University. He works as a vascular surgeon at the hospital and senior academic at the university. In his clinical position, he has noted the substantial increase in the burden of foot disease during his tenure at a regional vascular center. He directs a collaborative research group, named the Queensland Research Centre for Peripheral Vascular Disease, that focuses on improving understanding and management of vascular diseases, including diabetes-associated foot disease. The research has contributed to over 400 publications including laboratory and clinical research. He currently holds an NHMRC Practitioner Fellowship.
Michaela has been a clinical Podiatrist for over 20 years, specialising in the High Risk Foot in some of Victoria’s Major Metropolitan Hospitals. Her passion for patient centred high risk foot care, service delivery and improvement. She holds a Bachelor of Podiatry from La Trobe University and a Master’s Degree of Podiatry from Curtin University. Michaela is currently working at Eastern Health as the Director of Podiatry and the Allied Health Acute and Aged Medicine and Manager of Sub Acute Services. Along with her podiatry roles, she concurrently is the Project Officer for NADC Foot Network working on the National HRFS Standards and Accreditation Program.
Michaela is presenting at the DFA Mini Symposium on Sunday 08 October.
Laurens Manning (BSc, MBChB, DTM&H (London), FRACP, PhD) is an infectious disease physician and clinical researcher at Fiona Stanley Hospital (FSH), University of Western Australia and Telethon Kids Institute. An active ‘foot’ physician, he has developed the MDFU in-patient and outpatient services at FSH. He has a diverse research portfolio that includes design and implementation of clinical trials in diabetic foot infections, penicillin reformulation for rheumatic heart disease, peri-prosthetic joint infections and epidemiological studies of lower leg cellulitis in Australia. Elsewhere he leads clinical trials, observational and pharmacological studies in young PNG children with malaria and severe infections. In addition to a strong track record in research activities, he has extensive links with global health community, in particular as a researcher, teacher, external examiner and clinician in PNG. His role as an opinion leader is evidenced by his role in formulating national guidelines, drawing directly on his own research as in the case of writing the PNG Standard Adult Treatment Guidelines and in distilling and interpreting the literature for Therapeutic Guidelines Expert Writing Groups (Antibiotics/Dermatology). He has been appointed to the ASID Clinical Research Network steering group to facilitate collaborative studies in infectious diseases across Australia and New Zealand and the TGA advisory committee for biologicals which is creating the regulatory framework for faecal transplantation.
He has published a total of 90 papers in the past 10 years and 8 book chapters, supervises 4 PhD students and been the recipient of >$5M in tier 1 grants in the last 5 years including an MRFF Emerging Leadership Fellowship (2021-25).
Meet our
Partners!
DFA would like to introduce you to our wonderful partners who are an integral part of the DFA Conference. You can learn more by clicking on each partner listed below in the lead up to the conference.
OFFICIAL
CONFERENCE
PARTNER
At URGO Medical Australia, we are here to heal people. Our mission is to support healthcare professionals and make a difference in the lives of their patients. By providing evidence-based wound care treatment and support, we aim to work in partnership with healthcare professionals to move from managing wounds to healing wounds to help improve patient outcomes and reduce healing time. We have made the diabetic foot ulcer a key priority, with the aim to close wounds, save feet and save lives for patients with diabetes and eradicate amputations and death as a consequence of diabetic foot.
At URGO Medical Australia, we are here to heal people.
Our mission is to support healthcare professionals and make a difference in the lives of their patients. By providing evidence-based wound care treatment and support, we aim to work in partnership with healthcare professionals to move from managing wounds to healing wounds to help improve patient outcomes and reduce healing time. We have made the diabetic foot ulcer a key priority, with the aim to close wounds, save feet and save lives for patients with diabetes and eradicate amputations and death as a consequence of diabetic foot.
Advanced Pressure Mapping (APM) is the Australian supplier of Tekscan pressure mapping systems. APM specializes in providing the Fscan in-shoe system, that is the thinnest sensor available and the only trimmable sensor on the market currently. Alongside their range of systems, APM offers individual training, workshops, and ongoing support to ensure optimal utilization of you're pressure mapping system. Their services cater to healthcare professionals and researchers seeking to enhance their understanding and analysis of pressure distribution in various applications. APM's commitment to offering cutting-edge technology, customizable sensors, and comprehensive support sets them apart in the field of pressure mapping systems.
Base Medical prides itself on providing Australian healthcare with novel, quality, life-changing medical technology. As the exclusive Australian distributor of cyclical pressurised Topical Wound Oxygen (TWO2) therapy, Base Medical aims to reduce the burden of chronic lower extremity wounds and improve quality of life. Our mission is to work with patients, their carers and healthcare professionals to help durably heal their wounds, keep them out of hospital and reduce the rate of lower limb amputations in our country.
Oraderm Pharmaceuticals is an Australian specialist dermatology company founded in 2017. We specialise in supporting patients and health care professionals to find innovative solutions to manage debilitating conditions of the skin. Our recent innovation launch of BlastX Antimicrobial Biofilm Wound Gel is bringing HOPE to healing wounds. A hydrogel delivering 5 ways of action on bacterial, fungi, biofilm, preventing infection and maintain moist wounds for faster healing and scar mitigation. We love what we do and patients lives are at our centre!
Coloplast wants to make life easier for patients with wounds and simplify wound care for people who care for them. Working closely with the people who use our products, we create solutions that are specific to their needs. With a Coloplast solution, everyone can be certain they are doing their best. Not just because we offer the latest innovations in faster wound healing, but because we design them to be intuitive. Not just to experts, but to everyone else involved in healing a wound - the real users.
Together with them, we strive for fewer days with wounds.
Convatec is a global medical products and technologies company focused on solutions for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence & critical care, and infusion care. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.
DOLA Orthotics is your one stop solution for custom orthotics, prefabricated orthotics and DIY orthotic supplies. DOLA offers an orthotic to meet your prescription needs from prefabricated to custom, simple to complex and DIY to lab supply. Originally a traditional plaster lab founded by Australian Podiatrists in 2000. DOLA now supplies custom & prefabricated orthotics to medical professionals throughout Australia, United Kingdom, New Zealand, Asia, the Middle East and the United States.
Our custom orthotics are designed and manufactured in Australia using the latest in custom orthotic CAD/CAM and 3D Printing technology from your choice of cast, impression or 3D scan. Our extensive range of prefabricated orthotics and additions are designed by clinicians for clinicians to suit a wide range of patient types and usage options. Our range of exclusive DOLA products and education & training are designed to support you to provide everybody the orthotic they need. Be proud to prescribe your patients DOLA Orthotics
EBOS Healthcare is engrained in the Australasian Healthcare network, and we pride ourselves in connecting healthcare professionals to the world's best devices, consumables, pharmaceuticals, and vaccines. We focus on exploring and evaluating new solutions through collaboration with reputable global manufacturers with products that meet our customers’ needs. Our extensive market coverage allows us to follow and support healthcare practitioners and patients at all stages of their lives. We take pride in connecting healthcare professionals to the world's best devices, consumables, pharmaceuticals, and vaccines. To achieve this, we explore and evaluate new solutions through collaboration with reputable global manufacturers that share our values of quality, integrity, and trust.
HTFO is a specialty allied health enterprise based in Melbourne, Australia. Owned and operated by clinicians, HTFO provides clients and customers with a range of unique, innovative healthcare products. Formed in 2001 as a clinically focused business then expanding to wholesale distribution in 2007, HTFO has a strong history of excellent sales, service, and education in the B2B wholesale bracing and supports market in Australia and New Zealand. Currently HTFO offers the market expertise in the following areas:
- Distribution of Orthotics based clinical care products to the allied medical health care industry in Australia and New Zealand.
- Specialty central fabrication services to a growing number of P&O facilities in Australia and New Zealand.
- Client-direct care in Melbourne, Australia.
InterMed is a well-established distribution company which has been supplying the healthcare markets in Australia and New Zealand for over 40 years. We are proud to partner with a broad range of international and local suppliers to access well respected brands and quality products for our customers and their patients. Please join us as we highlight the NATROX® Oxygen Wound Therapy, eKare advanced mobile wound management platform and the Foot Defender, which is an AFO engineered from the ground up to protect the foot.
Lohmann & Rauscher (L&R) is a leading manufacturer of high-quality, innovative, healthcare products. L&R’s comprehensive range encompasses Wound Care, NPWT, Compression, Fracture Management and Drapes & Clinical Apparel offers. We offer our customers products that are innovative, performance focused and effective, meeting all relevant standards. L&R’s robust Quality Assurance procedures across our company owned manufacturing facilities, ensure our products provide consistently high quality and aligned performance, L&R has over 170 years’ expertise around the world, focusing on providing products that meet clinical needs and delight clinicians.
Contact Details
Email: info@au.lrmed.com
Phone: 1300 572 869
Medi-Rent is the leading provider of pneumatic compression pumps in Australia and New Zealand and we have gained enormous traction in the wounds market over the last few years. The Bio Arterial Plus Pump is indicated for the treatment of peripheral arterial disease, critical limb ischemia in patients without a surgical option and diabetic ulcers. Outcomes include: Improved arterial inflow, reduced claudication pain, immediate and sustained increase in walking distances and wound healing (arterial, neuropathic). To learn more about clinical application of the Bio Arterial pump we encourage you to attend our workshop on this topic. Medi-Rent provides an online Learning Hub to clinicians where you can learn more through modules, case studies and research summaries.
Medical Technologies Australia are a family owned company that distribute leading medical devices. The Fibroscan liver diagnostic can detect the presence of Nash and Fibrosis prevalent in T2DM. Metabolic scales break down body composition and shock wave therapy has successfully been used to treat diabetic foot ulcers.
To learn more head to our website https://medicaltechnologiesaustralia.com/
For over 40 years, OPC Health has provided a dedicated commitment to servicing major hospitals and allied health professionals right around the country. With contracts across major health area services and government bodies as a preferred supplier, OPC Health has accumulated extensive experience in delivering top-tier high-risk foot management and support for the diabetic community. Leveraging our deep understanding of products and clinical expertise, we offer a comprehensive product range tailored to address the unique challenges of high-risk foot management. Encompassing felts, foams, wound dressings, instrumentation, post-operative footwear, offloading devices, custom AFOs, and more. At OPC Health, we provide exceptional solutions that cater to the distinct requirements of individuals and professionals managing diabetes.
Revita is a biological 3-layer amniotic membrane allograft produced in Australia by SurgicalBiofix and distributed by CuraTech. Preserving all three layers of the placental membrane allows Revita to deliver the maximum concentration of components naturally found in the native tissue and provide a scaffold that mimics the natural architecture of the placental tissue. Revita retains about 6.55 times more growth factors and 4.3 times more protein content than similar solutions. Learn more about Revita and its applications at our booth or via website.
3M focuses on providing better care through patient-centered science. Helping transform outcomes by restoring patients’ lives through innovation. From our leading negative pressure and surgical incision management technologies to our comprehensive line of skin and advanced wound care solutions, we are focused on helping you provide the best care for your patients, resulting in the best possible outcomes.
The Australian Diabetes Society (ADS) is the peak national medical and scientific body in Australia for diabetes. The ADS is a member-based organisation consisting of endocrinologists, scientists, researchers, diabetes educators, primary care practitioners and allied health professionals
Advanced Pressure Mapping (APM) is the Australian supplier of Tekscan pressure mapping systems. APM specializes in providing the Fscan in-shoe system, that is the thinnest sensor available and the only trimmable sensor on the market currently. Alongside their range of systems, APM offers individual training, workshops, and ongoing support to ensure optimal utilization of you're pressure mapping system. Their services cater to healthcare professionals and researchers seeking to enhance their understanding and analysis of pressure distribution in various applications. APM's commitment to offering cutting-edge technology, customizable sensors, and comprehensive support sets them apart in the field of pressure mapping systems.
Base Medical prides itself on providing Australian healthcare with novel, quality, life-changing medical technology. As the exclusive Australian distributor of cyclical pressurised Topical Wound Oxygen (TWO2) therapy, Base Medical aims to reduce the burden of chronic lower extremity wounds and improve quality of life. Our mission is to work with patients, their carers and healthcare professionals to help durably heal their wounds, keep them out of hospital and reduce the rate of lower limb amputations in our country.
Oraderm Pharmaceuticals is an Australian specialist dermatology company founded in 2017. We specialise in supporting patients and health care professionals to find innovative solutions to manage debilitating conditions of the skin. Our recent innovation launch of BlastX Antimicrobial Biofilm Wound Gel is bringing HOPE to healing wounds. A hydrogel delivering 5 ways of action on bacterial, fungi, biofilm, preventing infection and maintain moist wounds for faster healing and scar mitigation. We love what we do and patients lives are at our centre!
Coloplast wants to make life easier for patients with wounds and simplify wound care for people who care for them. Working closely with the people who use our products, we create solutions that are specific to their needs. With a Coloplast solution, everyone can be certain they are doing their best. Not just because we offer the latest innovations in faster wound healing, but because we design them to be intuitive. Not just to experts, but to everyone else involved in healing a wound - the real users.
Together with them, we strive for fewer days with wounds.
Convatec is a global medical products and technologies company focused on solutions for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence & critical care, and infusion care. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.
DOLA Orthotics is your one stop solution for custom orthotics, prefabricated orthotics and DIY orthotic supplies. DOLA offers an orthotic to meet your prescription needs from prefabricated to custom, simple to complex and DIY to lab supply. Originally a traditional plaster lab founded by Australian Podiatrists in 2000. DOLA now supplies custom & prefabricated orthotics to medical professionals throughout Australia, United Kingdom, New Zealand, Asia, the Middle East and the United States.
Our custom orthotics are designed and manufactured in Australia using the latest in custom orthotic CAD/CAM and 3D Printing technology from your choice of cast, impression or 3D scan. Our extensive range of prefabricated orthotics and additions are designed by clinicians for clinicians to suit a wide range of patient types and usage options. Our range of exclusive DOLA products and education & training are designed to support you to provide everybody the orthotic they need. Be proud to prescribe your patients DOLA Orthotics
EBOS Healthcare is engrained in the Australasian Healthcare network, and we pride ourselves in connecting healthcare professionals to the world's best devices, consumables, pharmaceuticals, and vaccines. We focus on exploring and evaluating new solutions through collaboration with reputable global manufacturers with products that meet our customers’ needs. Our extensive market coverage allows us to follow and support healthcare practitioners and patients at all stages of their lives. We take pride in connecting healthcare professionals to the world's best devices, consumables, pharmaceuticals, and vaccines. To achieve this, we explore and evaluate new solutions through collaboration with reputable global manufacturers that share our values of quality, integrity, and trust.
HTFO is a specialty allied health enterprise based in Melbourne, Australia. Owned and operated by clinicians, HTFO provides clients and customers with a range of unique, innovative healthcare products. Formed in 2001 as a clinically focused business then expanding to wholesale distribution in 2007, HTFO has a strong history of excellent sales, service, and education in the B2B wholesale bracing and supports market in Australia and New Zealand. Currently HTFO offers the market expertise in the following areas:
- Distribution of Orthotics based clinical care products to the allied medical health care industry in Australia and New Zealand.
- Specialty central fabrication services to a growing number of P&O facilities in Australia and New Zealand.
- Client-direct care in Melbourne, Australia.
InterMed is a well-established distribution company which has been supplying the healthcare markets in Australia and New Zealand for over 40 years. We are proud to partner with a broad range of international and local suppliers to access well respected brands and quality products for our customers and their patients. Please join us as we highlight the NATROX® Oxygen Wound Therapy, eKare advanced mobile wound management platform and the Foot Defender, which is an AFO engineered from the ground up to protect the foot.
Lohmann & Rauscher (L&R) is a leading manufacturer of high-quality, innovative, healthcare products. L&R’s comprehensive range encompasses Wound Care, NPWT, Compression, Fracture Management and Drapes & Clinical Apparel offers. We offer our customers products that are innovative, performance focused and effective, meeting all relevant standards. L&R’s robust Quality Assurance procedures across our company owned manufacturing facilities, ensure our products provide consistently high quality and aligned performance, L&R has over 170 years’ expertise around the world, focusing on providing products that meet clinical needs and delight clinicians.
Contact Details
Email: info@au.lrmed.com
Phone: 1300 572 869
Medi-Rent is the leading provider of pneumatic compression pumps in Australia and New Zealand and we have gained enormous traction in the wounds market over the last few years. The Bio Arterial Plus Pump is indicated for the treatment of peripheral arterial disease, critical limb ischemia in patients without a surgical option and diabetic ulcers. Outcomes include: Improved arterial inflow, reduced claudication pain, immediate and sustained increase in walking distances and wound healing (arterial, neuropathic). To learn more about clinical application of the Bio Arterial pump we encourage you to attend our workshop on this topic. Medi-Rent provides an online Learning Hub to clinicians where you can learn more through modules, case studies and research summaries.
Medical Technologies Australia are a family owned company that distribute leading medical devices. The Fibroscan liver diagnostic can detect the presence of Nash and Fibrosis prevalent in T2DM. Metabolic scales break down body composition and shock wave therapy has successfully been used to treat diabetic foot ulcers.
To learn more head to our website https://medicaltechnologiesaustralia.com/
For over 40 years, OPC Health has provided a dedicated commitment to servicing major hospitals and allied health professionals right around the country. With contracts across major health area services and government bodies as a preferred supplier, OPC Health has accumulated extensive experience in delivering top-tier high-risk foot management and support for the diabetic community. Leveraging our deep understanding of products and clinical expertise, we offer a comprehensive product range tailored to address the unique challenges of high-risk foot management. Encompassing felts, foams, wound dressings, instrumentation, post-operative footwear, offloading devices, custom AFOs, and more. At OPC Health, we provide exceptional solutions that cater to the distinct requirements of individuals and professionals managing diabetes.
Revita is a biological 3-layer amniotic membrane allograft produced in Australia by SurgicalBiofix and distributed by CuraTech. Preserving all three layers of the placental membrane allows Revita to deliver the maximum concentration of components naturally found in the native tissue and provide a scaffold that mimics the natural architecture of the placental tissue. Revita retains about 6.55 times more growth factors and 4.3 times more protein content than similar solutions. Learn more about Revita and its applications at our booth or via our website.
3M focuses on providing better care through patient-centered science. Helping transform outcomes by restoring patients’ lives through innovation. From our leading negative pressure and surgical incision management technologies to our comprehensive line of skin and advanced wound care solutions, we are focused on helping you provide the best care for your patients, resulting in the best possible outcomes.
The Australian Diabetes Society (ADS) is the peak national medical and scientific body in Australia for diabetes. The ADS is a member-based organisation consisting of endocrinologists, scientists, researchers, diabetes educators, primary care practitioners and allied health professionals